ESMO 2022 On-Demand Presentations

Genomic profiling in precision oncology is transforming cancer care for patients.
But long waiting periods for biomarker test results can delay therapy decisions.

Access on-demand content from our ESMO symposium and discover how next generation sequencing (NGS) results can be achieved in as little as 24 hours, providing you genomic biomarker data in parallel to histologic diagnosis.

Connecting patients everywhere to precision oncology

The evolving paradigm of precision
medicine in lung cancer: what oncologist
and advocacies can do

Silvia Novello MD, University of Turin, Italy

> Download Slides

 

Lung cancer: how do I ask for and
use molecular profiling results to guide
everyday treatment decisions?

Edurne Arriola MD, Hospital Del Mar, Spain

> Download Slides

 

Next generation sequencing solution
for every laboratory: my experience

Beatriz Bellosillo PhD, Hospital Del Mar, Spain

> Download Slides

 

Circulating tumour DNA for monitoring of response to neoadjuvant chemotherapy in patients with high grade serous ovarian carcinoma

Elin Gray PhD, Edith Cowan University, Australia

> Download Slides

 

Fully automated end-to-end IVD solution
for ultra fast NGS results? Yes, we can.

Chiara Rolando PhD, Thermo Fisher Scientific

> Download Slides

 

Request to speak with a Thermo Fisher Scientific representative below.

 

 

Discover the power of NGS for your clinical lab with Ion Torrent Genexus Dx Integrated Sequencer a fast, flexible, and automated CE-marked IVD system.